Denali Therapeutics Inc (DNLI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account
Sell

$12.51

Buy

$14.49

arrow-down$-0.30 (-2.22%)

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Prices updated at 31 May 2025, 00:03 EDT
| Prices minimum 15 mins delay
|
Prices in USD
$13.45 - $12.92
$33.33 - $10.57
-
1,923.46m
-
-
1,205,599
1.71
1,109,011.29
0.89
144.22m
US24823R1059
-2.67
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.